Optimization of renin-angiotensin-aldosterone inhibitor therapies for evidence-based indications: A call to action from the cardio-kidney community

Authors

• Roberto Pecoits-Filho, Arbor Research Collaborative for Health, Ann Arbor, Michigan, USA.
• Michelle M. Wong, Division of Nephrology, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
• Monica Moorthy, International Society of Nephrology, Brussels, Belgium.
• Debasish Banerjee, Renal and Transplantation Unit, St George's University Hospitals NHS Foundation Trust, Molecular and Clinical Sciences Research Institute, St George's University of London, London, UK.
• Suman Behera, Division of Nephrology, Southlake Regional Health And Michael G. DeGroote School of Medicine, McMaster University.
• Viviane Calice-Silva, Research Department, Pro-rim Foundation and School of Medicine, UNIVILLE, Joinville, SC, Brazil.
• Mogamat-Yazied Chothia, Division of Nephrology, Department of Medicine, Stellenbosch University, Cape Town, South Africa.
• Gates B. Colbert, Department of Nephrology, Texas A&M College of Medicine, Dallas, Texas, USA.
• Martha Gulati, Barbra Streisand Women's Heart Center, Department of Cardiology, Cedars Sinai Heart Institute, Los Angeles, California, USA.
• Charles A. Herzog, Cardiology Division, Dept. of Medicine, Hennepin Healthcare/University of Minnesota, Minneapolis, Minnesota, USA.
• Fadi Jouhra, Cardiology Department, St George's University Hospitals NHS Foundation Trust, Cardiology Clinical Academic Group, Molecular and Clinical Sciences Research Institute, St George's University of London, London, UK.
• Edgar V. Lerma, Advocate Health - MidwestFollow
• Charu Malik, International Society of Nephrology, Brussels, Belgium.
• Kershaw V. Patel, Center for Cardiovascular Prevention, Ascension Texas Cardiovascular, Dell School of Medicine, Austin, Texas, USA.
• Amina Rakisheva, Cardiology Department, Scientific Research Institute of Cardiology and Internal Medicine, Almaty, Kazakhstan.
• Giuseppe M. Rosano, Centre for Clinical and Basic Research, IRCCS San Raffaele, Rome, Italy.
• Priyanka Satish, Center for Cardiovascular Prevention, Ascension Texas Cardiovascular, Dell School of Medicine, Austin, Texas, USA.
• Henry H. Wu, Renal Research, Kolling Institute of Medical Research, Royal North Shore Hospital & The University of Sydney, Sydney, Australia.
• Angela Yee-Moon Wang, Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong Special Administrative Region, China.

Recommended Citation

Pecoits-Filho R, Wong MMY, Moorthy M, et al. Optimization of renin-angiotensin-aldosterone inhibitor therapies for evidence-based indications: a call to action from the cardio-kidney community. ESC Heart Fail. 2025;12(4):2597-2604. doi:10.1002/ehf2.15262

Affiliations

Advocate Christ Medical Center

Document Type

Editorial

PubMed ID

40488540